Contact
Please use this form to send email to PR contact of this press release:
Genticel Reports Additional Results at 12 Months From Phase 2 Trial of HPV Immunotherapeutic Candidate, GTL001
TO:
Please use this form to send email to PR contact of this press release:
Genticel Reports Additional Results at 12 Months From Phase 2 Trial of HPV Immunotherapeutic Candidate, GTL001
TO: